YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting

GAITHERSBURG, Md., Dec. 21, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of...